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Introduction
Cardiac resynchronization therapy-deﬁbrillator (CRT-D) devices are indicated for patients with moderate-to-severe left
ventricular (LV) dysfunction to restore cardiac function,
improve symptoms, and reduce morbidity and mortality.1,2
LV resynchronization is traditionally achieved through a pacing lead through the coronary sinus to a lateral branch and the
deﬁbrillator lead in the right ventricular (RV) apex. However,
there is an w8% technique failure rate,3 in addition to patients who do not have favorable anatomy for a traditional
approach like mechanical tricuspid valve, as well as patients
who experience recurrent device infection endocarditis.
Several hybrid approaches for CRT-D placement are not uncommon. We describe a case of a patient with various prior
episodes of device endocarditis and limited transvenous options who has an indication for CRT-D device placement.

Case report
The patient is a 55-year-old woman with diabetes mellitus,
coronary artery disease, long QT syndrome with ventricular
tachycardia, LV systolic dysfunction, and permanent atrial
ﬁbrillation. She previously had a left-sided implantable cardiac deﬁbrillator (ICD) implanted initially in 2001 (with
generator change in 2010), complicated by a high burden
of RV pacing with consequent severe LV dysfunction
requiring biventricular (BiV) upgrade in 2015 with normalization of LV function. She later developed endocarditis and
pocket infection requiring extraction and reimplantation of
a right-sided BiV ICD in 2018 (Figure 1A). The left-sided
pocket was debrided, resulting in extensive scarring. The
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KEY TEACHING POINTS
 Recurrent device infection and endocarditis are not
uncommon and still the most important limiting
factor when considering subcutaneous-transvenous
device placement.
 Various approaches to left ventricular
resynchronization therapy are available for patients
in whom resynchronization therapy is indicated,
and minimally invasive surgical approach is a
valuable alternative approach when the routine
subcutaneous-transvenous system is not optional.
 A hybrid subcutaneous (over the sternum)/surgical
biventricular epicardial cardiac resynchronization
therapy-deﬁbrillator system using a minimally
invasive minithoracotomy with epicardial pacing
and subcutaneous implantable cardiac deﬁbrillator
leads connected to a single abdominal generator is
a novel approach for patients with limited bilateral
transvenous anatomy and failed deﬁbrillation
threshold testing with an epicardial system.
patient responded to resynchronization therapy with both
devices, with borderline normal LV systolic function over
several years.
She is now admitted with methicillin-resistant Staphylococcus aureus bacteremia. Her echocardiogram revealed
vegetations on the atrial lead. She was therefore referred to
our center for device extraction and further management.
Her device was interrogated. Upon decreasing of the
lower ventricular rate, she had frequent polymorphic premature ventricular complexes, nonsustained polymorphic ventricular tachycardia, and ventricular ﬁbrillation (Figure 1B)
requiring appropriate ICD shock by the bedside. Her ventricular arrhythmias were suppressed with BiV pacing. A
BiV-ICD system was recommended.
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Figure 1 A: Old right-sided biventricular (BiV) implantable cardiac deﬁbrillator (ICD) with new epicardial cardiac resynchronization therapydeﬁbrillator (CRT-D) system. B: Ventricular ﬁbrillation. C: Biventricular pacing with QRS 110 ms. D: New hybrid epicardial and subcutaneous biventricular ICD. LA 5 left atrial; LV 5 left ventricular; RV 5 right ventricular.

Given her limited transvenous access, we implanted an
epicardial BiV pacing system with 1 pericardial coil (DF1
model 6935; Medtronic, Minneapolis, MN) using a minithoracotomy at the left ﬁfth intercostal space (Supplemental
Figure 1, label D). We implanted 2 epicardial LV (Medtronic
4968-60 and Medtronic 5071-53) and 2 RV leads (Medtronic
4968-60) in case of ventricular lead failure in the future. All
leads had normal pacing and sensing thresholds. Only 1 ICD
coil (Medtronic 693565) lead along the base of the heart
could be placed, as the posterior epicardial space could not
be accessed further. The leads were capped and tunneled to
an abdominal pocket. We considered a subcutaneous ICD
as an alternative approach for the ICD part. However, since
the subcutaneous ICD system relies on preimplantation
QRS-T morphology screening to assure it will reliably detect
QRS complexes and T waves, we elected to place the epicardial ICD coil at the time of her surgery in case if she failed the
screening and the need for a second cardiac surgery in this
case.
The patient was brought later for a generator placement
with deﬁbrillation threshold (DFT) testing and the possible
addition of subcutaneous coil (Figure 1A). DFT testing using
the current epicardial system was unsuccessful. A DF1 lead
(Medtronic 6935-58) was tunneled and placed subcutaneously over the sternum. The coil was connected to the generator (Medtronic DTPB2D1), and the pace-sense part was
capped. There was good BiV-pacing (Figure 1C), and her

DFT testing after including the new subcutaneous coil was
successful. Her right-sided BiV-ICD was successfully extracted afterward (Figure 1D) using serial gentle traction technique for the LV and right atrial lead. The ICD lead required
an EZ locking stylet with serial gentle traction. There were no
periprocedural complications. She was discharged on a prolonged course of 8 weeks of intravenous antibiotics. Her device function was normal at 6 weeks follow-up, and her
echocardiogram revealed an unchanged borderline normal
LV systolic function with no pericardial effusion.

Discussion
Surgical approaches for epicardial ICD lead implantation
have been extensively described with various surgical techniques and hybrid approaches.4 Most epicedial CRT-D devices require a mid-sternotomy approach with generator
commonly placed in the left or right pectoral area.4 To our
knowledge only 2 published cases for adults with completely
epicardial implantable CRT-D devices have been placed using a minithoracotomy approach with 2 epicardial ICD coils
and abdominal generator. In the ﬁrst case, a right atrial lead
was not required, similar to our patient, and in the second
case a robotic system approach was used.4,5 To our knowledge, we report the ﬁrst case of a hybrid subcutaneous/surgical BiV-CRT-D system with epicardial and subcutaneous
ICD leads connected to a single abdominal generator using
a minimally invasive surgical approach.
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DFT testing was not successful in our case, likely because
of the location and short distance between the RV-ICD coil
and the generator, with the deﬁbrillation vector likely not
traversing through sufﬁcient myocardial tissue. We may
have avoided this obstacle had a second posterior or posterolateral ICD coil lead been successfully implanted along the
base of the heart at the time of surgery. This option was not
available to us in this case, as it would have required further
extension of the surgical incision or full midsternal thoracotomy approach, per our surgical team. We could also avoid the
need for the parasternal coil if the generator could be placed
in the left upper chest position, but this was not a feasible option, given her history of a prior pocket infection with extensive debridement and scar tissue. Furthermore, considering a
more lateral midaxillary location for the ICD might allow for
better shock vector. However, we felt that the parasternal
ICD lead/coil would still be needed for successful DFT,
and since the DFT testing was successful after that we did
not consider moving the generator to the lateral midaxillary
line. Finally, and in retrospect, both procedures could have
been combined in an electrophysiology / cardiac surgery
team approach. Nonetheless, careful presurgical planning is
warranted in such complicated multi-approach procedures.

Conclusion
We describe a case of a patient who required CRT-D therapy
with multiple prior CRT-D device endocarditis and pocket
infection. We used a novel alternative implantation approach
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using a minimally invasive minithoracotomy for a hybrid surgical epicardial BiV CRT-D system and subcutaneous (above
the sternum) ICD lead connected to a single abdominal
generator.

Appendix
Supplementary data
Supplementary data associated with this article can be found
in the online version at https://doi.org/10.1016/j.hrcr.2022.
07.002.

References
1. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused
update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based
therapy of cardiac rhythm abnormalities: a report of the American College of
Cardiology Foundation/American Heart Association Task Force on Practice
Guidelines and the Heart Rhythm Society. Circulation 2013;127:
e283–e352.
2. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac
pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:
3427–3520.
3. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in
patients with heart failure and intraventricular conduction delay. N Engl J Med
2001;344:873–880.
4. Tonko JB, Blauth C, Rosenthal E, Rinaldi CA. Completely epicardial implantable
cardioverter/deﬁbrillator (ICD) and CRT-D systems: a case series and systematic
literature review. Pacing Clin Electrophysiol 2021;44:1616–1630.
5. Amraoui S, Labrousse L, Jansens J-L, Sohal M, Bordachar P, Ritter P. Implantation
of a cardiac resynchronization therapy and deﬁbrillation system using a robotic
approach. HeartRhythm Case Rep 2015;1:356–359.

